Significant progress in mesothelioma clinical trials indicates a bright future ahead

21 Aug 2014 by under Organizations, Research/Treatment

MARF logo square Significant progress in mesothelioma clinical trials indicates a bright future aheadMary Hesdorffer,  executive director of the Applied Research Foundation (Meso Foundation), spoke during the organization’s July 2014 board meeting about the advances in for mesothelioma patients, which is allowing them to aid mesothelioma patients more effectively. Ms. Hesdorffer is a nurse practitioner with more than 16 years of experience in mesothelioma treatment.

According to Hesdorffer, the advances in clinical trials have not only improved survival and response rates, but have brought new treatments – and hope – to the forefront of the battle against mesothelioma. After receiving a positive response of 69 percent in one novel trial, Hesdorffer says that the trial will be done again on a much broader scale to confirm these potentially groundbreaking results.

“A clinical trial is a unique opportunity for a patient to try something new and innovative that could have a very positive impact on the patient’s disease,” said Ms. Hesdorffer. “Having options is an important step forward in a disease that merely a decade ago was seen as hopeless,” she added.

Mesothelioma is a rare type of cancer that most often affects the lining of the lungs or abdomen. Rarely, it can also affect the lining of the heart. Mesothelioma is caused by exposure to asbestos. Even in tiny amounts, asbestos exposure can be dangerous. Microscopic asbestos fibers may be inhaled or ingested, leading to the development of cancerous tissue. There is currently no known cure for mesothelioma.

The Mesothelioma Applied Research Foundation is a national organization that offers several patient services, including free consultations regarding clinical trials and other patient issues. The Foundation is dedicated to finding a cure and eradicating mesothelioma as a life-ending disease by funding the highest quality and most promising mesothelioma research projects from around the world; helping mesothelioma patients connect with national mesothelioma experts and obtain the most up-to-date information on treatment options; and acting as an advocate for federal mesothelioma research funding to stop this national tragedy.

“While health care providers aren’t able to review all clinical trial options with their patients due to time constrains, at the Meso Foundation it is our job to spend the necessary time to go through all viable options while taking into consideration insurance coverage, stage of disease, histology and readiness to participate in a clinical trial,” added Ms. Hesdorffer.

In order to better educate the mesothelioma community on the current state of affairs in the area of research and treatment, the Mesothelioma Applied Research Foundation created a downloadable brochure regarding the latest clinical trials, which may also be requested by mail, and all of the information on the clinical trials may also be found on its website.

Source:
Mesothelioma Applied Research Foundation

 

Comments are closed.